10076 Federal Register / Vol. 74, No. 44 / Monday, March 9, 2009 / Notices 

8 In particular, I rely on the prescriptions Dr. 

Aghaegbuna issued to residents of California, 

Hawaii, and Texas. In preparing this Order, I have 

visited the Web sites of the medical licensing 

authorities of these States and verified that Dr. 

Aghaegbuna was not licensed by them. 

I have also visited the Web sites of the respective 

State authorities of Illinois, Michigan, and New 

Hampshire, and determined that Dr. Burr was not 

licensed in these States. Respondent nonetheless 

dispensed prescriptions issued by Dr. Burr for 

residents of these States in violation of state and 

Federal laws. 

9Respondent also had ample reason to know that 

prescriptions were unlawful because he knew that 

the prescribers were not physically examining the 

patients. As Mr. Ihenacho wrote in a March 8, 2007 

e-mail, ‘‘I do not feel very comfortable at all feeling 

[sic] medications where I know that there is really 

no doctor/patient interaction.’’ Indeed, under 

numerous State medical practice standards, with 

only limited exceptions, a physician must take a 

medical history and physically examine a patient in 

order to properly diagnose the patient and 

recommend treatment options including prescribing 

a drug. See, e.g., N.J. Admin. Code 13:35–7.1A(a); 

S.C. Code Regs. 81–28. 

10To make clear, I would have revoked 

Respondent’s registration had it not expired prior 

to the issuance of this Order. 

practitioner [be] licensed under the laws 

of this State’’). 

As I have previously explained, an 

entity which voluntarily engages in 

commerce by shipping controlled 

substances to persons located in other 

States is properly charged with 

knowledge of the laws regarding both 

the practice of medicine and pharmacy 

in those States. United, 72 FR at 50408. 

In short, given that Dr. Aghaegbuna was 

licensed to practice medicine in 

Virginia, and yet was prescribing to 

persons who did not reside in that State 

and who frequently lived hundreds of— 

and in many instances more than a 

thousand—miles away,8 Respondent 

had ample reason to know that the 

prescriptions were unlawful under both 

the CSA and the laws of numerous 

States. See id. at 50409.9

As the forgoing demonstrates, 

Respondent knowingly violated Federal 

law in dispensing thousands of 

prescriptions which lacked a 

legitimated purpose and were issued by 

practitioners acting outside of the usual 

course of professional practice. 21 CFR 

1306.04(a). Respondent’s experience in 

dispensing controlled substances is thus 

characterized by its repeated and 

flagrant violations of both the CSA and 

State laws; the scope of its illegal 

dispensings clearly establish that its 

continued registration was ‘‘inconsistent 

with the public interest,’’ and posed ‘‘an 

imminent danger to the public health or 

safety’’ which warranted the immediate 

suspension of its registration.10 21 

U.S.C. 824(a) & (d). 

Order 

Pursuant to the authority vested in me 

by 21 U.S.C. 824, as well as 28 CFR 

0.100(b) & 0.104, I affirm my order 

which immediately suspended the nowexpired DEA Certificate of Registration, 

BM3972747, issued to Meetinghouse 

Community Pharmacy, Inc. This order is 

effective immediately. 

Dated: February 26, 2009. 

Michele M. Leonhart, 

Deputy Administrator. 

[FR Doc. E9–4909 Filed 3–6–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated November 26, 2008, 

and published in the Federal Register 

on December 5, 2008, (73 FR 74194), 

Cerilliant Corporation, 811 Paloma 

Drive, Suite A, Round Rock, Texas 

78665–2402, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

Cathinone (1235) ......................................................................................................................................................................................... I 

Methcathinone (1237) .................................................................................................................................................................................. I 

N-Ethylamphetamine (1475) ........................................................................................................................................................................ I 

N,N-Dimethylamphetamine (1480) .............................................................................................................................................................. I 

Fenethylline (1503) ...................................................................................................................................................................................... I 

Gamma hydroxybutyric acid (2010) ............................................................................................................................................................ I 

Ibogaine (7260) ........................................................................................................................................................................................... I 

Lysergic acid diethylamide (7315) ............................................................................................................................................................... I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine(7348) ................................................................................................................................ I 

Marihuana (7360) ........................................................................................................................................................................................ I 

Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I 

Mescaline (7381) ......................................................................................................................................................................................... I 

3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................ I 

4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. I 

4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... I 

4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. I 

2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I 

3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I 

3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ I 

3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ I 

4-Methoxyamphetamine (7411) ................................................................................................................................................................... I 

Alpha-methyltryptamine (7432) ................................................................................................................................................................... I 

Diethyltryptamine (7434) ............................................................................................................................................................................. I 

Dimethyltryptamine (7435) .......................................................................................................................................................................... I 

Psilocybin (7437) ......................................................................................................................................................................................... I 

Psilocyn (7438) ............................................................................................................................................................................................ I 

N-Benzylpiperazine (7493) .......................................................................................................................................................................... I 

Etorphine (except HCl) (9056) .................................................................................................................................................................... I 

Heroin (9200) ............................................................................................................................................................................................... I 

Morphine-N-oxide (9307) ............................................................................................................................................................................. I 

Normorphine (9313) .................................................................................................................................................................................... I 

Pholcodine (9314) ....................................................................................................................................................................................... I 

Dextromoramide (9613) ............................................................................................................................................................................... I 

Dipipanone (9622) ....................................................................................................................................................................................... I 

Trimeperidine (9646) ................................................................................................................................................................................... I 


dwashington3 on PROD1PC60 with NOTICES
Federal Register / Vol. 74, No. 44 / Monday, March 9, 2009 / Notices 10077 

1The Order also noted that on March 10, 2003, 

Respondent had surrendered his DEA registration, 

that in February 2004, the Missouri State Board for 

the Healing Arts had entered into a settlement 

agreement with Respondent under which his 

medical license was placed on probation for seven 

years, and that in April 2006, Respondent’s state 

controlled substances registration had been 

restored. Id. at 1–2. 

Drug Schedule 

Amphetamine (1100) ................................................................................................................................................................................... II 

Methamphetamine (1105) ........................................................................................................................................................................... II 

Methylphenidate (1724) ............................................................................................................................................................................... II 

Amobarbital (2125) ...................................................................................................................................................................................... II 

Pentobarbital (2270) .................................................................................................................................................................................... II 

Secobarbital (2315) ..................................................................................................................................................................................... II 

Phencyclidine (7471) ................................................................................................................................................................................... II 

Phenylacetone (8501) ................................................................................................................................................................................. II 

Cocaine (9041) ............................................................................................................................................................................................ II 

Codeine (9050) ............................................................................................................................................................................................ II 

Dihydrocodeine (9120) ................................................................................................................................................................................ II 

Oxycodone (9143) ....................................................................................................................................................................................... II 

Hydromorphone (9150) ............................................................................................................................................................................... II 

Benzoylecgonine (9180) .............................................................................................................................................................................. II 

Ethylmorphine (9190) .................................................................................................................................................................................. II 

Meperidine (9230) ....................................................................................................................................................................................... II 

Methadone (9250) ....................................................................................................................................................................................... II 

Dextropropoxyphene, bulk (non-dosage forms) (9273) .............................................................................................................................. II 

Morphine (9300) .......................................................................................................................................................................................... II 

Oripavine (9330) .......................................................................................................................................................................................... II 

Thebaine (9333) .......................................................................................................................................................................................... II 

Levo-alphacetylmethadol (9648) ................................................................................................................................................................. II 

Oxymorphone (9652) ................................................................................................................................................................................... II 

Fentanyl (9801) ........................................................................................................................................................................................... II 

The company plans to import small 

quantities of the listed controlled 

substances for the manufacture of 

analytical reference standards. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Cerilliant Corporation to import the 

basic classes of controlled substances is 

consistent with the public interest, and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated 

Cerilliant Corporation to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: March 4, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–4945 Filed 3–6–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. 06–78] 

Steven M. Abbadessa, D.O.; Grant of 

Restricted Registration 

On August 7, 2006, the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, issued an Order to 

Show Cause to Steven M. Abbadessa, 

D.O. (Respondent), of St. Louis, 

Missouri. The Show Cause Order 

proposed the denial of Respondent’s 

pending application for a DEA 

Certificate of Registration as a 

practitioner, on the ground that his 

‘‘registration would be inconsistent with 

the public interest.’’ Id. at 1 (citing 21 

U.S.C. 823(f)). 

The Show Cause Order specifically 

alleged that ‘‘[o]n or about January 1981, 

[Respondent] illegally possessed and 

distributed * * * cocaine in violation of 

21 U.S.C. 841(a)(1),’’ that Respondent 

was subsequently charged and arrested, 

and that he had admitted to agents that 

he had been involved ‘‘in the illegal 

distribution of cocaine, a schedule II 

controlled substance,’’ but that ‘‘no 

further prosecution was undertaken’’ 

because he cooperated with authorities. 

Id. 

The Show Cause Order next alleged 

that on December 4, 2001, Respondent 

was arrested by local police at a hotel 

in Clayton, Missouri, where he was 

found to have in his possession cocaine, 

as well as two prescription controlled 

substances—a combination drug 

containing hydrocodone, a schedule III 

controlled substance, and alprazolam, a 

schedule IV controlled substance. Id. 

The Order further alleged that the 

hydrocodone and the alprazolam ‘‘had 

been dispensed in the name of an 

acquaintance’’ of Respondent. Id. 

Relatedly, the Show Cause Order 

alleged that Respondent was 

subsequently indicted in state court on 

one felony count of possession of 

cocaine, and two felony counts of 

obtaining controlled substances by 

fraud. Id. The Order further alleged that 

on January 31, 2003, Respondent pled 

guilty to all three counts, but that he 

was allowed to withdraw his pleas after 

he completed a ‘‘one-year drug 

program.’’ 1 Id. at 1–2. 

Respondent, through his counsel, 

requested a hearing on the allegations. 

ALJ Ex. 2. The matter was assigned to 

Administrative Law Judge (ALJ) Gail 

Randall, who conducted a hearing in St. 

Louis, Missouri, on May 15 and 16, 

2007. At the hearing, both the 

Government and Respondent put on 

testimony and introduced documentary 

evidence into the record. Following the 

hearing, both parties submitted briefs 

containing their proposed findings of 

fact, conclusions of law, and argument. 

On February 13, 2008, the ALJ issued 

her recommended decision (ALJ). In her 

decision, the ALJ concluded that the 


dwashington3 on PROD1PC60 with NOTICES